
The antibiotics are needed to combat key drug-resistant bacteria causing severe bloodstream and urinary tract infections, pneumonia and meningitis

The UK regulator highlights its century-long role in establishing safety and consistency benchmarks

The partnership will provide financial support and strengthen early detection and intervention efforts

The new antibiotic class targets two of the WHO’s ‘priority pathogens’

The company plans head-to-head safety evaluation with COVID-19 vaccine, pending regulatory alignment

Globally, five billion doses of the companies’ vaccine have been distributed

Global health authorities have recommended that vaccines for the 2025-2026 season should target LP.8.1

Kostaive is designed to instruct the body to make more mRNA to boost immune response

President Donald Trump said the agency mishandled the COVID-19 pandemic and other global health crises

The appeal is aimed at providing urgent humanitarian assistance to more than 300 million people

The combined vaccine approach could simplify immunisation practices and lead to higher uptake

Lagevrio is already available in the US under emergency use authorisation to treat certain cases of COVID-19